JESSICA BAGLEY: Open Payments
NPI 1285885731 · BATTLE CREEK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 24 payments from 8 companies in 2025. Trend: 2023 $45 · 2024 $242 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 15 | $137 |
| Regeneron Healthcare Solutions, Inc. | 2 | $60 |
| Viatris Specialty LLC | 2 | $59 |
| Grifols USA, LLC | 1 | $34 |
| Pulmonx Corporation | 1 | $29 |
| Insmed, Inc. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: TRELEGY ELLIPTA, DUPIXENT, YUPELRI, NUCALA, Prolastin-C Liquid, CHARTIS CATHETER, Arikayce, JASCAYD.
Industry payments across MI — which companies pay providers there.
